Latest Coronavirus Disease COVID 19 News and Research
Yale researchers develop new mouse model to study SARS-CoV-2 infection
Researchers at Yale University School of Medicine have developed a new mouse model to study SARS-CoV-2 infection and disease and to accelerate testing of novel treatments and vaccines against the novel coronavirus.
Maryland County pledges investigation of health worker’s coronavirus death
Officials in Maryland's Prince George's County say they "will spare no time or expense" investigating the circumstances surrounding the death of a veteran public health worker who died of COVID-19 after relatives and co-workers believe she contracted the coronavirus on the job.
When green means stop: How safety messages got so muddled
When Marquita Burnett heard Philadelphia was moving to the "green" phase of reopening, she was confused. She was pretty sure the city had already earned a green designation from Pennsylvania's governor (it had). The next thing she knew, the city was scaling back some of the businesses it had planned to reopen (namely, indoor dining and gyms). But it was still calling this phase "restricted green."
Study shows health anxieties have increased as a result of ongoing pandemic
New research into people's coping strategies faced with COVID-19 highlights the mental health toll for those shielding
Researchers initiate multiple studies to identify coronavirus-related heart problems
COVID-19 is shown to impact the heart and, in some cases, have long-lasting cardiac effects. To discover the extent to which COVID-19 affects the heart, cardiologists and researchers with the University of Miami Miller School of Medicine have begun multiple studies.
How COVID-19 lockdown affected the heart
A new study published on the preprint server medRxiv in August 2020 shows that heart rate variability assessments, used to evaluate the health of the heart and blood vessels, are useful in identifying changes in health and well being throughout lockdown related to COVID-19.
Five alternative methods of SARS-CoV-2 suppression
The current pandemic has proved to be challenging to control without stringent and comprehensive non-pharmacological interventions (NPIs), relying mostly on isolation and contact tracing of cases, along with social distancing. However, strategies like these have a huge human cost in terms of restriction of social interactions, resulting in depressive tendencies, disruption of economic activity, and loss of educational resources.
Low-income communities lack access to ICU beds
A new Penn Medicine study sheds light on yet another reason why the coronavirus pandemic is disproportionately killing the poor: Residents in low-income neighborhoods lack access to intensive care unit (ICU) beds.
Study identifies possible therapeutic treatment for COVID-19
Yunjeong Kim and Kyeong-Ok "KC" Chang, virologists in the College of Veterinary Medicine at Kansas State University, have published a study showing a possible therapeutic treatment for COVID-19.
A new platform to provide information on SARS-CoV-2 immunity or seroprevalence
Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way that will provide information on immunity or seroprevalence in the population.
Research explains recognized sex differences in COVID-19 outcomes
The COVID-19 pandemic has notably taken a more significant toll on men compared to women, in terms of both disease severity and death. Now, a new study by researchers at the Icahn School of Medicine at Mount Sinai and published on the preprint server medRxiv in August 2020 confirms the increased risk that males have for death following COVID-19 while also highlighting worse outcomes in women with coronary artery disease, obesity, and hypoxia compared to men.
Extensive study of SARS-CoV-2 sequencing reveals six strains of the virus
The virus causing the COVID-19 pandemic, SARS-CoV-2, presents at least six strains. Despite its mutations, the virus shows little variability, and this is good news for the researchers working on a viable vaccine.
Study shows high SARS-CoV-2 seroprevalence, but low death rate in Malawi's health care workers
A study by researchers from Malawi and United Kingdom reveals a significant discrepancy between predicted coronavirus disease (COVID-19) mortality in the observed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence rates in health care workers and reported deaths in urban Malawi in southeastern Africa, indicating early exposure, but a slow progression of the outbreak. Their findings are currently available on the medRxiv preprint server.
SARS-CoV-2 lured away and trapped by a new decoy version of ACE2
Researchers in the United States and Canada have engineered affinity-optimized “receptor traps” that prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from binding to and infecting cells.
California GOP consultant rues ‘big mistake’ that led to family’s COVID infections
The tweet Richard Costigan posted July 23 was bluntly honest: "We tried our best to limit exposure to #COVID19 but we slipped up somewhere."
Novel short ACE2 isoform may influence SARS-CoV-2 susceptibility
A study led by researchers at the University of Southampton, UK, has identified a novel short isoform of the full-length receptor that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses to gain entry to host cells.
Study evaluates how travel bans help reduce the spread of COVID-19
With the reopening of flights during the summer holiday season in Europe, many countries have started to see an increase in COVID-19 infections.
Oxford University and ZOE join forces to widen access to COVID-19 treatment trials
Oxford University and the COVID Symptom Study app are joining forces to widen access to two clinical trials of potential treatments for COVID-19.
Cloth face masks have potential to reduce the transmission of SARS-CoV-2 viruses
A literature review coordinated by Karolinska Institutet in Sweden and McMaster University in Canada demonstrates that cloth face masks provide clinically useful levels of filtration, which has the potential to reduce the spread of viruses such as SARS-CoV-2.
Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test
Oxford Nanopore today announces an agreement with the UK’s Department of Health and Social Care, to roll out its novel LamPORE test.
No hay comentarios:
Publicar un comentario